Table 2.
Hospital encounter outcomes and resource utilization in cardiogenic shock patients
| Hospital Outcomes no. (%) | AMI-CS† Not undergoing revascularization (n = 62,883) | AMI-CS undergoing revascularization (n = 55,735) | All patients of AMI-CS (n = 118,618) | p value |
|---|---|---|---|---|
| Died at discharge | 32816 (52.2%) | 14017 (25.1%) | 46833 (39.5%) | <0.01 |
| Died at discharge males | 18138 (51.7%) | 8378 (23.2%) | 26516 (37.3%) | <0.01 |
| Died at discharge females | 14677 (52.80%) | 5637 (28.60%) | 20314 (42.80%) | <0.01 |
| Discharge Disposition of surviving patients | ||||
| Routine/self-care | 7344 (24.40%) | 19529 (46.80%) | 26873 (37.40%) | <0.01 |
| Short-term hospital | 5605 (18.60%) | 2487 (6.00%) | 8092 (11.30%) | |
| Another type of facility | 12131 (40.30%) | 11832 (28.40%) | 23963 (33.40%) | |
| Home Health Care | 4712 (15.70%) | 7652 (18.30%) | 12364 (17.20%) | |
| Resource utilization | ||||
| PCI‡ | 0 | 384829 (69.0%) | 384829 (32.4%) | <0.01 |
| CABG§ | 0 | 19128 (34.30%) | 19128 (16.10%) | <0.01 |
| Vasopressors | 4342 (6.9%) | 2765 (5.0%) | 7107 (6.0%) | <0.01 |
| CPR¶ | 8139 (12.90%) | 4373 (7.80%) | 12512 (10.50%) | <0.01 |
| ECMO# | 220 (0.30%) | 18625 (33.40%) | 18845 (15.90%) | <0.01 |
| Intra-aortic balloon pump | 12056 (18.6%) | 30993 (57.5%) | 43049 (36.3%) | <0.01 |
| PVADs†† | 548 (0.8%) | 1096 (2%) | 1644 (1.4%) | <0.01 |
| Mechanical ventilation | 34808 (55.4%) | 21464 (38.5%) | 56272 (47.4%) | <0.01 |
| Tracheostomy | 2341 (3.70%) | 2624 (4.70%) | 4965 (4.20%) | <0.01 |
| Gastrostomy | 1682 (2.70%) | 1141 (2.00%) | 2823 (2.40%) | <0.01 |
| Length of stay, mean (SD), days | 8.75 (12.071) | 11.49 (12.075) | 10.04 (12.15) | <0.01 |
| Cost of hospitalization-mean (SD), $ | 101,123 (156,007) | 176,131 (168,821) | 136,541 (166,450) | <0.01 |
†
Acute myocardial infarction-cardiogenic shock.
‡
Per Cutaneous coronary intervention.
§
Coronary artery bypass graft.
¶
cardiopulmonary resuscitation.
#
Extracorporeal membrane oxygenation.
††
Percutaneous ventricular assist devices.